Related Experiment Video
Updated: Feb 26, 2026

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
5.0K
Mitochondrial Dysfunction Mediated by Poly(ADP-Ribose) Polymerase-1 Activation Contributes to Hippocampal Neuronal
Yi-Chen Lai1, J Scott Baker2, Taraka Donti3
1Departments of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA. ylai@bcm.edu.
International Journal of Molecular Sciences
|July 15, 2017
Summary
Poly(ADP-ribose) polymerase-1 (PARP-1) hyperactivation worsens mitochondrial dysfunction after status epilepticus (SE). Inhibiting PARP-1 preserves energy metabolism and neuronal survival, suggesting it as a therapeutic target for SE.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Epilepsy Research
Background:
- Mitochondrial dysfunction is key in status epilepticus (SE) neuropathology and epilepsy development.
- Excitotoxicity is a known factor, but PARP-1's role in SE-induced mitochondrial issues is unclear.
Purpose of the Study:
- To investigate the contribution of poly(ADP-ribose) polymerase-1 (PARP-1) hyperactivation to mitochondrial dysfunction following SE.
- To assess the impact of PARP-1 inhibition on neuronal survival and mitochondrial function post-SE.
Main Methods:
- Measured poly-ADP-ribosylated protein levels as a marker of PARP-1 activity after kainic acid-induced SE.
- Assessed NAD+ levels and NAD+-dependent mitochondrial respiration using enzymatic cycling and polarography.
- Evaluated neuronal cell loss in the hippocampus and the effects of PARP-1 inhibitor PJ-34.
Main Results:
- PARP-1 was hyperactive 24 hours post-SE, accompanied by decreased NAD+ levels and impaired mitochondrial respiration.
- Significant CA1 and CA3 hippocampal neuronal loss was observed 72 hours post-SE.
- PARP-1 inhibition preserved NAD+ levels, maintained mitochondrial respiration, and improved CA1 neuronal survival.
Conclusions:
- PARP-1 hyperactivation contributes to mitochondrial dysfunction and neuronal damage in SE.
- Intracellular NAD+ depletion mediates some of the negative effects of PARP-1 on mitochondrial respiration.
- Modulating PARP-1 activity offers a potential therapeutic strategy for preserving mitochondrial function after SE.

